Long-term Follow-up and/or Continued Thalidomide (THALOMID®) Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2017
At a glance
- Drugs Thalidomide (Primary)
- Indications Mantle-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 10 Dec 2015 Planned primary completion date changed from 1 Aug 2020 to 1 Nov 2020 as reported by ClinicalTrials.gov record.
- 10 Dec 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 24 Jul 2015 New trial record